Target intelligence / Profile preview

Reactive Oxygen Species and Oxidative Stress Mediators (ROS/Oxidative Stress)

Target
ROS/Oxidative Stress
Molecular classification
Other
01

Overview

Broad cellular free radicals and oxidative/inflammatory processes refer to the systemic accumulation of reactive oxygen species (ROS) and reactive nitrogen species (RNS) that overwhelm cellular antioxidant defenses, leading to oxidative stress (Pizzino et al., 2017) [1]. These reactive species, including superoxide anions and hydroxyl radicals, are produced during mitochondrial respiration and by enzymes like NADPH oxidase, playing dual roles as both damaging agents and essential signaling molecules (NIH/NCI) [2]. When unregulated, they cause oxidative damage to DNA, proteins, and lipids, which in turn triggers pro-inflammatory signaling pathways such as the NF-κB cascade (Reuter et al., 2010) [3]. This interplay between oxidative stress and inflammation is a central driver in the progression of chronic diseases, including neurodegeneration, atherosclerosis, and various cancers (Halliwell, 2006) [4]. Pharmacological intervention typically involves the use of radical scavengers like Edaravone or antioxidants like N-acetylcysteine to neutralize these species or enhance endogenous defense mechanisms (Watanabe et al., 2018) [5]. However, the lack of specificity in targeting these broad processes remains a significant challenge, as ROS are also required for normal physiological functions like immune defense and cellular adaptation (Forman & Zhang, 2021) [6].

Other names
Free radicalsReactive Oxygen SpeciesROSReactive Nitrogen SpeciesRNSOxidative stressCellular oxidative damagePro-inflammatory oxidative processes
02

Mechanism of action

Direct scavenging of reactive oxygen and nitrogen species, and induction of endogenous antioxidant enzyme systems (e.g., via Nrf2 activation).

03

Biological functions

Signal transductionImmune responseCell deathRedox homeostasisMetabolic regulation
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseDiabetesAging-related pathology
05

Safety considerations

Interference with essential redox signalingPotential pro-oxidant effects at high concentrationsInhibition of ROS-dependent apoptosis in malignant cellsLack of clinical efficacy in large-scale antioxidant trials
06

Interacting drugs

Edaravone

5 more in the full profile.

07

Biomarkers

8-hydroxy-2'-deoxyguanosine (8-OHdG)Malondialdehyde (MDA)Protein carbonylsF2-isoprostanesGSH/GSSG ratio

Beyond the preview

Go deeper on Reactive Oxygen Species and Oxidative Stress Mediators (ROS/Oxidative Stress).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive Oxygen Species and Oxidative Stress Mediators (ROS/Oxidative Stress).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call